{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:09:33Z","timestamp":1788174573382,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa-DGOS-INSERM-ITMO Cancer_18008"],"award-info":[{"award-number":["INCa-DGOS-INSERM-ITMO Cancer_18008"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa_19428"],"award-info":[{"award-number":["INCa_19428"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007394","name":"Association Laurette Fugain","doi-asserted-by":"publisher","award":["ALF 2021\/06"],"award-info":[{"award-number":["ALF 2021\/06"]}],"id":[{"id":"10.13039\/100007394","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41375-026-02901-w","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:00:31Z","timestamp":1773057631000},"page":"806-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3565-2709","authenticated-orcid":false,"given":"Doroth\u00e9e","family":"Selimoglu-Buet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-2172","authenticated-orcid":false,"given":"Valeria","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Th\u00e9pot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-8766","authenticated-orcid":false,"given":"Lionel","family":"Ad\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0185-3323","authenticated-orcid":false,"given":"Lucie","family":"Laplane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristoteles","family":"Giagounidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6099-5324","authenticated-orcid":false,"given":"Nathalie","family":"Droin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-1650","authenticated-orcid":false,"given":"Michael","family":"L\u00fcbbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sapena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Nimubona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Miguel","family":"Torregrosa-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Germing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Pelizzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6162-515X","authenticated-orcid":false,"given":"Nadja","family":"Jaekel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Metzgeroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-3474","authenticated-orcid":false,"given":"Francesco","family":"Onida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciane","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Patriarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aspasia","family":"Stamatoullas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6276-8002","authenticated-orcid":false,"given":"Katharina","family":"G\u00f6tze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatiha","family":"Chermat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1863-3239","authenticated-orcid":false,"given":"Uwe","family":"Platzbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8629-1341","authenticated-orcid":false,"given":"Eric","family":"Solary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2139-6262","authenticated-orcid":false,"given":"Raphael","family":"Itzykson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2901_CR1","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41375-021-01207-3","volume":"35","author":"O Chan","year":"2021","unstructured":"Chan O, Renneville A, Padron E. Chronic myelomonocytic leukemia diagnosis and management. Leukemia. 2021;35:1552\u201362.","journal-title":"Leukemia"},{"key":"2901_CR2","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","volume":"31","author":"R Itzykson","year":"2013","unstructured":"Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M, et al. Prognostic score including gene mutations in chronic myelomonocytic leukemia. J Clin Oncol. 2013;31:2428\u201336.","journal-title":"J Clin Oncol"},{"key":"2901_CR3","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1182\/blood-2012-08-452938","volume":"121","author":"E Such","year":"2013","unstructured":"Such E, Germing U, Malcovati L, Cervera J, Kuendgen A, Della Porta MG, et al. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood. 2013;121:3005\u201315.","journal-title":"Blood"},{"key":"2901_CR4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","volume":"128","author":"C Elena","year":"2016","unstructured":"Elena C, Galli A, Such E, Meggendorfer M, Germing U, Rizzo E, et al. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016;128:1408\u201317.","journal-title":"Blood"},{"key":"2901_CR5","doi-asserted-by":"crossref","unstructured":"Tefferi A, Fathima S, Abdelmagid M, Alsugair A, Aperna F, Rezasoltani M, et al. BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia. Blood 2025;146:874\u201386.","DOI":"10.1182\/blood.2024027170"},{"key":"2901_CR6","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/leu.2013.88","volume":"27","author":"MM Patnaik","year":"2013","unstructured":"Patnaik MM, Padron E, LaBorde RR, Lasho TL, Finke CM, Hanson CA, et al. Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia. 2013;27:1504\u201310.","journal-title":"Leukemia"},{"key":"2901_CR7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/cncr.23697","volume":"113","author":"H Kantarjian","year":"2008","unstructured":"Kantarjian H, O\u2019Brien S, Ravandi F, Cortes J, Shan J, Bennett JM, et al. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer. 2008;113:1351\u201361.","journal-title":"Cancer"},{"key":"2901_CR8","doi-asserted-by":"crossref","unstructured":"Deschamps P, Wacheux M, Gosseye A, Morabito M, Pages A, Lyne AM, et al. CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia. J Clin Invest 2024;134:e180738.","DOI":"10.1172\/JCI180738"},{"key":"2901_CR9","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1182\/blood-2015-01-620781","volume":"125","author":"D Selimoglu-Buet","year":"2015","unstructured":"Selimoglu-Buet D, Wagner-Ballon O, Saada V, Bardet V, Itzykson R, Bencheikh L, et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood. 2015;125:3618\u201326.","journal-title":"Blood"},{"key":"2901_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41375-020-0955-1","volume":"35","author":"M Jestin","year":"2021","unstructured":"Jestin M, Tarfi S, Duchmann M, Badaoui B, Freynet N, Tran Quang V, et al. Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study. Leukemia. 2021;35:893\u20136.","journal-title":"Leukemia"},{"key":"2901_CR11","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41375-025-02620-8","volume":"39","author":"D Tremblay","year":"2025","unstructured":"Tremblay D, Hasserjian RP, Rampal RK. Myelodysplastic syndrome\/myeloproliferative neoplasm overlap syndromes: a practical guide to diagnosis and management. Leukemia. 2025;39:1311\u201324.","journal-title":"Leukemia"},{"key":"2901_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000150","volume":"2","author":"R Itzykson","year":"2018","unstructured":"Itzykson R, Fenaux P, Bowen D, Cross NCP, Cortes J, De Witte T, et al. Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet. Hemasphere. 2018;2:e150.","journal-title":"Hemasphere"},{"key":"2901_CR13","first-page":"22","volume":"110","author":"L Marando","year":"2025","unstructured":"Marando L, Csizmar CM, Patnaik MM. Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations. Haematologica. 2025;110:22\u201336.","journal-title":"Haematologica"},{"key":"2901_CR14","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2014-10-607341","volume":"125","author":"MR Savona","year":"2015","unstructured":"Savona MR, Malcovati L, Komrokji R, Tiu RV, Mughal TI, Orazi A, et al. An international consortium proposal of uniform response criteria for myelodysplastic\/myeloproliferative neoplasms (MDS\/MPN) in adults. Blood. 2015;125:1857\u201365.","journal-title":"Blood"},{"key":"2901_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.41","volume":"7","author":"M Duchmann","year":"2017","unstructured":"Duchmann M, Braun T, Micol JB, Platzbecker U, Park S, Pilorge S, et al. Validation of response assessment according to international consortium for MDS\/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents. Blood Cancer J. 2017;7:e562.","journal-title":"Blood Cancer J"},{"key":"2901_CR16","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1182\/blood.V88.7.2480.bloodjournal8872480","volume":"88","author":"E Wattel","year":"1996","unstructured":"Wattel E, Guerci A, Hecquet B, Economopoulos T, Copplestone A, Mahe B, et al. A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Francais des Myelodysplasies and European CMML Group. Blood. 1996;88:2480\u20137.","journal-title":"Blood"},{"key":"2901_CR17","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1200\/JCO.22.00437","volume":"41","author":"R Itzykson","year":"2023","unstructured":"Itzykson R, Santini V, Thepot S, Ades L, Chaffaut C, Giagounidis A, et al. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network. J Clin Oncol. 2023;41:1888\u201397.","journal-title":"J Clin Oncol"},{"key":"2901_CR18","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.3324\/haematol.2019.219782","volume":"105","author":"S Tarfi","year":"2020","unstructured":"Tarfi S, Badaoui B, Freynet N, Morabito M, Lafosse J, Toma A, et al. Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with an associated inflammatory state. Haematologica. 2020;105:e147\u2013e152.","journal-title":"Haematologica"},{"key":"2901_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2025.104009","volume":"6","author":"M Morabito","year":"2025","unstructured":"Morabito M, Solary E, Selimoglu-Buet D. Protocol for quantification of circulating immature granulocytes in patients with a chronic myeloid malignancy using flow cytometry. STAR Protoc. 2025;6:104009.","journal-title":"STAR Protoc"},{"key":"2901_CR20","first-page":"4273","volume":"130","author":"S Tarfi","year":"2017","unstructured":"Tarfi S, Harrivel V, Dumezy F, Guy J, Roussel M, Mimoun A, et al. Multicentric Validation of the \u201cMonocyte Assay\u201d for Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry. Blood. 2017;130:4273\u20134273.","journal-title":"Blood"},{"key":"2901_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07801-x","volume":"9","author":"D Selimoglu-Buet","year":"2018","unstructured":"Selimoglu-Buet D, Riviere J, Ghamlouch H, Bencheikh L, Lacout C, Morabito M, et al. A miR-150\/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset. Nat Commun. 2018;9:5455.","journal-title":"Nat Commun"},{"key":"2901_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1182\/blood.V128.22.109.109","volume":"128","author":"S Niyongere","year":"2016","unstructured":"Niyongere S, Lucas N, Sansil S, Cubitt CL, Balasis ME, Kroeger J, et al. Comprehensive Inflammatory Cytokine Profiling Identifies IL-8\/CXCL8 As Elevated, Associated with Proliferative Features, and Independently Prognostic in Chronic Myelomonocytic Leukemia (CMML). Blood. 2016;128:109\u2013109.","journal-title":"Blood"},{"key":"2901_CR23","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","volume":"121","author":"R Itzykson","year":"2013","unstructured":"Itzykson R, Kosmider O, Renneville A, Morabito M, Preudhomme C, Berthon C, et al. Clonal architecture of chronic myelomonocytic leukemias. Blood. 2013;121:2186\u201398.","journal-title":"Blood"},{"key":"2901_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10767","volume":"7","author":"J Merlevede","year":"2016","unstructured":"Merlevede J, Droin N, Qin T, Meldi K, Yoshida K, Morabito M, et al. Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents. Nat Commun. 2016;7:10767.","journal-title":"Nat Commun"},{"key":"2901_CR25","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/S2352-3026(20)30374-4","volume":"8","author":"L Pleyer","year":"2021","unstructured":"Pleyer L, Leisch M, Kourakli A, Padron E, Maciejewski JP, Xicoy Cirici B, et al. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study. Lancet Haematol. 2021;8:e135\u2013e148.","journal-title":"Lancet Haematol"},{"key":"2901_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106640","volume":"109","author":"AM Hunter","year":"2021","unstructured":"Hunter AM, Al Ali N, Mai A, Shah S, Swoboda DM, Kuykendall A, et al. Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy. Leuk Res. 2021;109:106640.","journal-title":"Leuk Res"},{"key":"2901_CR27","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1158\/1078-0432.CCR-21-0935","volume":"27","author":"AM Hunter","year":"2021","unstructured":"Hunter AM, Newman H, Dezern AE, Steensma DP, Niyongere S, Roboz GJ, et al. Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia. Clin Cancer Res. 2021;27:6095\u2013105.","journal-title":"Clin Cancer Res"},{"key":"2901_CR28","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1182\/blood.2024025648","volume":"144","author":"AM Hunter","year":"2024","unstructured":"Hunter AM, Patnaik MM, Itzykson R, Mesa R, Karanes C, Li Y, et al. Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm. Blood. 2024;144:1987\u201392.","journal-title":"Blood"},{"key":"2901_CR29","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1182\/blood.2023023476","volume":"143","author":"F Onida","year":"2024","unstructured":"Onida F, Gagelmann N, Chalandon Y, Kobbe G, Robin M, Symeonidis A, et al. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee. Blood. 2024;143:2227\u201344.","journal-title":"Blood"},{"key":"2901_CR30","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/s41375-019-0447-3","volume":"33","author":"N Lucas","year":"2019","unstructured":"Lucas N, Duchmann M, Rameau P, Noel F, Michea P, Saada V, et al. Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia. Leukemia. 2019;33:2466\u201380.","journal-title":"Leukemia"},{"key":"2901_CR31","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1182\/bloodadvances.2020002415","volume":"4","author":"AA Mangaonkar","year":"2020","unstructured":"Mangaonkar AA, Reichard KK, Binder M, Coltro G, Lasho TL, Carr RM, et al. Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia. Blood Adv. 2020;4:5425\u201330.","journal-title":"Blood Adv"},{"key":"2901_CR32","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41375-024-02511-4","volume":"39","author":"HM Addinsell","year":"2025","unstructured":"Addinsell HM, Cant R, Hull NJ, Wang YH, Somervaille TCP, Wiseman DH, et al. Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarization. Leukemia. 2025;39:770\u20134.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02901-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02901-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02901-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:37:11Z","timestamp":1775558231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02901-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2901"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-02901-w","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}